Literature DB >> 9816252

Telomerase activity in human bladder cancer.

Y Lin1, H Miyamoto, K Fujinami, H Uemura, M Hosaka, Y Iwasaki, Y Kubota.   

Abstract

Telomerase can synthesize telomeric DNA repeats onto chromosome ends. Telomere length and telomerase activity have recently been implicated in the control of the proliferative capacity of normal and malignant cells. The expression of telomerase activity is concomitant with the attainment of immortality in tumor tissues and cells. Thus, enzyme activity may indicate a prevalent or even ubiquitous tumor producer. In this report, telomerase activity was analyzed in 40 human bladder cancers, 7 normal tissues, and 2 bladder epithelia with dysplasia using a PCR-based telomeric repeat amplification protocol assay. Telomerase activity was detected in almost all bladder tumors (97.5%); only one sample, which was in an early stage, did not express telomerase activity. None of the normal tissues displayed telomerase activity. One of the two bladder epithelia with dysplasia expressed low telomerase activity. The expression of telomerase activity has a clear association with the pathological grade and clinical stage. Most of the tumors with high telomerase activity were in an advanced grade and had deep invasion. Thus, telomerase activity might be suggested to represent an additional required event in the multigenetic process of tumorigenesis in human bladder cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9816252

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  27 in total

1.  A rapid, useful and quantitative method to measure telomerase activity by hybridization protection assay connected with a telomeric repeat amplification protocol.

Authors:  M Hirose; J Abe-Hashimoto; K Ogura; H Tahara; T Ide; T Yoshimura
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

2.  Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer.

Authors:  Sumit Borah; Linghe Xi; Arthur J Zaug; Natasha M Powell; Garrett M Dancik; Scott B Cohen; James C Costello; Dan Theodorescu; Thomas R Cech
Journal:  Science       Date:  2015-02-05       Impact factor: 47.728

3.  Thyroid autoantibodies, telomerase activity, vascular endothelial growth factor, and bone scanning.

Authors:  A van Ophoven; B Patel; M K Rauch; A Belldegrun
Journal:  Rev Urol       Date:  1999

4.  Expression of steroid hormone receptors and its prognostic significance in urothelial carcinoma of the upper urinary tract.

Authors:  Eiji Kashiwagi; Kazutoshi Fujita; Seiji Yamaguchi; Hiroaki Fushimi; Hiroki Ide; Satoshi Inoue; Taichi Mizushima; Leonardo O Reis; Rajni Sharma; George J Netto; Norio Nonomura; Hiroshi Miyamoto
Journal:  Cancer Biol Ther       Date:  2016-09-16       Impact factor: 4.742

5.  Evaluation of Sienna Cancer Diagnostics hTERT Antibody on 500 Consecutive Urinary Tract Specimens.

Authors:  Derek B Allison; Rajni Sharma; Morgan L Cowan; Christopher J VandenBussche
Journal:  Acta Cytol       Date:  2018-06-06       Impact factor: 2.319

6.  Concomitant reduction of matrix metalloproteinase-2 secretion and intracellular reactive oxygen species following anti-sense inhibition of telomerase activity in PC-3 prostate carcinoma cells.

Authors:  Ahmad Shariftabrizi; Mohammad Reza Khorramizadeh; Farshid Saadat; Kamran Alimoghadam; Farnaz Safavifar; Mohammad Reza Ebrahimkhani
Journal:  Mol Cell Biochem       Date:  2005-05       Impact factor: 3.396

7.  Organ-wide telomeric status in diseased and disease-free prostatic tissues.

Authors:  Christopher M Heaphy; Trisha M Fleet; Eric G Treat; Sang-Joon Lee; Anthony Y Smith; Michael S Davis; Jeffrey K Griffith; Edgar G Fischer; Marco Bisoffi
Journal:  Prostate       Date:  2010-09-15       Impact factor: 4.104

8.  Telomerase activity detected by quantitative assay in bladder carcinoma and exfoliated cells in urine.

Authors:  R Fedriga; R Gunelli; O Nanni; F Bacci; D Amadori; D Calistri
Journal:  Neoplasia       Date:  2001 Sep-Oct       Impact factor: 5.715

9.  DNAzyme-based probes for telomerase detection in early-stage cancer diagnosis.

Authors:  Hui Wang; Michael J Donovan; Ling Meng; Zilong Zhao; Youngmi Kim; Mao Ye; Weihong Tan
Journal:  Chemistry       Date:  2013-02-20       Impact factor: 5.236

10.  Antitumor effects of specific telomerase inhibitor GRN163 in human glioblastoma xenografts.

Authors:  Tomoko Ozawa; Sergei M Gryaznov; Lily J Hu; Krisztina Pongracz; Raquel A Santos; Andrew W Bollen; Kathleen R Lamborn; Dennis F Deen
Journal:  Neuro Oncol       Date:  2004-07       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.